<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Immuno-oncology

Microbiome-Oncology Interactions: The Forgotten Axis in Cancer Progression

12 minute read

Microbiome-Oncology Interactions: The Forgotten Axis in Cancer Progression

March 7, 2025

How Can High Content Imaging Transform Your Cancer Research?

12 minute read

How Can High Content Imaging Transform Your Cancer Research?

November 22, 2024

OX40 Agonists: Boosting Cancer Immunotherapy

7 minute read

OX40 Agonists: Boosting Cancer Immunotherapy

October 18, 2024

Key Differences between hPBMC and hCD34 Humanized Mouse Models

6 minute read

Key Differences between hPBMC and hCD34 Humanized Mouse Models

July 10, 2024

Understanding the Cancer-Immunity Cycle to Improve Cancer Immunotherapy Development

6 minute read

Understanding the Cancer-Immunity Cycle to Improve Cancer Immunotherapy Development

July 11, 2023

Using Tumor Organoids and 3D Ex Vivo Microtumors for Immuno-Oncology Applications

9 minute read

Using Tumor Organoids and 3D Ex Vivo Microtumors for Immuno-Oncology Applications

June 22, 2022

How to Detect, Characterize, and Evaluate CAR-Ts: Top 13 Questions

4 minute read

How to Detect, Characterize, and Evaluate CAR-Ts: Top 13 Questions

October 5, 2021

Profiling of Tumor-Infiltrating Immune Cells in Syngeneic Tumor Models to Support Drug Development

4 minute read

Profiling of Tumor-Infiltrating Immune Cells in Syngeneic Tumor Models to Support Drug Development

March 1, 2021

The Rising Importance of GITR Agonists as Alternative I/O Candidates for Combination Drug Strategies

6 minute read

The Rising Importance of GITR Agonists as Alternative I/O Candidates for Combination Drug Strategies

November 30, 2020

Evaluating Immunotherapy Mechanism of Action with Immune Cell Lineage-Specific DTR Models

5 minute read

Evaluating Immunotherapy Mechanism of Action with Immune Cell Lineage-Specific DTR Models

October 14, 2020